| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |